Stock NOVO B NOVO NORDISK A/S
Add to a list
To use this feature you must be a member
Log inSign up

News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Market Closed - Nasdaq Copenhagen
Other stock markets
 10:59:45 2024-04-23 am EDT 		5-day change 1st Jan Change
891.3 DKK +1.83% Intraday chart for Novo Nordisk A/S +2.74% +27.68%
Apr. 22 Health Care Climbs on Earnings Hopes -- Health Care Roundup DJ
Apr. 22 Eli Lilly to acquire manufacturing facility from Nexus Pharma RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Health Care Climbs on Earnings Hopes -- Health Care Roundup
DJ
Eli Lilly to acquire manufacturing facility from Nexus Pharma
RE
Novo Nordisk A/S - share repurchase programme
GL
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
AQ
India's Biocon developing its own version of Wegovy, clinical trial likely next year
RE
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GL
Novo Nordisk A/S - share repurchase programme
GL
More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm
RE
Biophytis: patent application filed in the field of obesity
CF
Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup
DJ
European Equities Close Mixed in Friday Trading; German Inflation Slows, UK GDP Rises
MT
Weight-Loss Drugs Like Wegovy Don't Cause Suicidal Thoughts, EU Says
DJ
Sector Update: Health Care Stocks Steady Pre-Bell Friday
MT
Novo Nordisk's Wegovy, Ozempic Have No Added Suicide Risk, EU Says
MT
European Medicines Agency Finds No Increased Suicide Risk Linked to Weight-loss Drugs
MT
Novo Nordisk's Wegovy, Ozempic Have No Added Suicide Risk, EU Says
MT
European Medicines Agency Finds No Increased Suicide Risk Link to Novo Nordisk's Wegovy, Ozempic
MT
BMO Capital Starts Novo Nordisk With Outperform Rating, $163 Price Target
MT
EU regulator finds no link between weight-loss drugs and suicidal thoughts
RE
Gerresheimer shares down on outlook, but key contracts confirmed
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

We are working hard...
  • We are working hard to come back as soon as possible.
  • Nous travaillons dur pour revenir au plus vite.
  • Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
  • Estamos trabajando duro para volver lo antes posible.
  • Stiamo lavorando sodo per tornare il prima possibile.
  • Wij werken hard om zo snel mogelijk weer terug te zijn.
503 Backend fetch failed
  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. News Novo Nordisk A/S